RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)

CUSIP: 75629V104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Class A Stock
Shares outstanding
525,302,736
Total 13F shares
106,463,853
Share change
+11,625,285
Total reported value
$861,094,172
Put/Call ratio
76%
Price per share
$8.14
Number of holders
130
Value change
+$96,496,440
Number of buys
72
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAILLIE GIFFORD & CO
13F
Company
mixed-class rows
189,734,284
mixed-class rows
$833,431,000 31 Mar 2022
13F
GENERAL ATLANTIC, L.P.
13F
Individual
24%
90,810,814
$365,968,000 31 Mar 2022
13F
ARK Investment Management LLC
13F
Company
mixed-class rows
67,360,803
mixed-class rows
$280,313,000 31 Mar 2022
13F
Anchorage Capital Group, L.L.C.
13F
Company
18%
69,158,354
$278,708,000 31 Mar 2022
13F
VIKING GLOBAL INVESTORS LP
13F
Company
13%
51,055,144
$205,752,000 31 Mar 2022
13F
Senator Investment Group LP
13F
Company
12%
46,015,343
$175,955,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
mixed-class rows
35,944,759
mixed-class rows
$165,552,000 31 Mar 2022
13F
Lux Ventures IV, L.P.
3/4/5
Former 10% Owner
class O/S missing
13,021,519
$137,710,376 07 Dec 2021
BlackRock Finance, Inc.
13F
Company
mixed-class rows
22,660,907
mixed-class rows
$112,320,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
mixed-class rows
25,120,064
mixed-class rows
$101,674,000 31 Mar 2022
13F
Amova Asset Management Americas, Inc.
13F
Company
mixed-class rows
15,336,256
mixed-class rows
$64,290,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
mixed-class rows
11,093,660
mixed-class rows
$48,756,000 31 Mar 2022
13F
Obvious Management Services, L.L.C.
13F
Company
1.1%
5,977,631
$42,800,000 31 Mar 2022
13F
Data Collective IV GP, LLC
13F
Company
1.1%
5,941,120
$42,538,000 31 Mar 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
mixed-class rows
9,393,368
mixed-class rows
$39,615,000 31 Mar 2022
13F
Laurion Capital Management LP
13F
Company
0.87%
4,587,274
$32,845,000 31 Mar 2022
13F
HRT FINANCIAL LP
13F
Company
mixed-class rows
7,655,747
mixed-class rows
$31,018,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
mixed-class rows
5,918,802
mixed-class rows
$29,858,000 31 Mar 2022
13F
DCVC Opportunity Fund II GP, LLC
13F
Company
0.75%
3,951,141
$28,290,000 31 Mar 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.64%
3,380,718
$24,206,000 31 Mar 2022
13F
Casdin Capital, LLC
13F
Company
mixed-class rows
4,750,964
mixed-class rows
$20,862,000 31 Mar 2022
13F
FMR LLC
13F
Company
mixed-class rows
2,145,799
mixed-class rows
$15,364,000 31 Mar 2022
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.41%
2,136,604
$15,298,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
mixed-class rows
3,372,311
mixed-class rows
$14,759,000 31 Mar 2022
13F
MIC Capital Partners (Public) Parallel Cayman, LP
3/4/5
10%+ Owner
class O/S missing
1,388,889
$14,688,335 01 Nov 2021
NORTHERN TRUST CORP
13F
Company
mixed-class rows
2,856,487
mixed-class rows
$14,202,000 31 Mar 2022
13F
MV Management XI, L.L.C.
13F
Company
0.38%
1,971,908
$14,119,000 31 Mar 2022
13F
Ensign Peak Advisors, Inc
13F
Company
mixed-class rows
3,461,882
mixed-class rows
$14,001,000 31 Mar 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
mixed-class rows
3,217,256
mixed-class rows
$13,130,000 31 Mar 2022
13F
Two Sigma Ventures, LP
13F
Company
0.34%
1,806,800
$12,937,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
mixed-class rows
2,667,995
mixed-class rows
$12,302,000 31 Mar 2022
13F
CREDIT SUISSE AG/
13F
Company
mixed-class rows
1,811,222
mixed-class rows
$12,196,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
mixed-class rows
2,823,167
mixed-class rows
$11,775,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
mixed-class rows
2,742,601
mixed-class rows
$11,315,000 31 Mar 2022
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.29%
1,509,254
$10,806,000 31 Mar 2022
13F
ALLEN OPERATIONS LLC
13F
Company
mixed-class rows
2,466,653
mixed-class rows
$10,622,000 31 Mar 2022
13F
NORGES BANK
13F
Company
0.27%
1,397,275
$10,004,489 31 Mar 2022
13F
MIC Capital Management UK LLP
13F
Company
0.26%
1,388,889
$9,944,000 31 Mar 2022
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.25%
1,336,750
$9,571,000 31 Mar 2022
13F
ArchPoint Investors
13F
Company
0.24%
1,267,430
$9,075,000 31 Mar 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.58%
2,211,760
$8,913,000 31 Mar 2022
13F
Neuberger Berman Group LLC
13F
Company
0.53%
2,037,386
$8,210,000 31 Mar 2022
13F
Comprehensive Financial Management LLC
13F
Company
0.21%
1,109,395
$7,943,000 31 Mar 2022
13F
Mitsubishi UFJ Trust & Banking Corp
13F
Company
mixed-class rows
1,639,220
mixed-class rows
$7,774,000 31 Mar 2022
13F
Blue Water Life Science Advisors, LP
13F
Company
0.47%
1,781,684
$7,180,000 31 Mar 2022
13F
Erste Asset Management GmbH
13F
Company
mixed-class rows
1,733,500
mixed-class rows
$7,089,855 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
mixed-class rows
1,537,700
mixed-class rows
$6,755,000 31 Mar 2022
13F
EQUITEC PROPRIETARY MARKETS, LLC
13F
Company
0.43%
1,662,456
$6,700,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
mixed-class rows
944,782
mixed-class rows
$6,656,000 31 Mar 2022
13F
PLUSTICK MANAGEMENT LLC
13F
Company
0.41%
1,550,000
$6,247,000 31 Mar 2022
13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q2 2022

As of 30 Jun 2022, RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 106,463,853 shares. The largest 10 holders included BAILLIE GIFFORD & CO, MIC Capital Management UK LLP, BlackRock Inc., VANGUARD GROUP INC, Obvious Management Services, L.L.C., Data Collective IV GP, LLC, Laurion Capital Management LP, NORGES BANK, DCVC Opportunity Fund II GP, LLC, and ALLIANCEBERNSTEIN L.P.. This page lists 130 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
124
Q2 2022 holders
130
Holder diff
6
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .